4.2 Article

Rat Prefrontal Dopamine and Cognitive Control: Impaired and Enhanced Conflict Performance

期刊

BEHAVIORAL NEUROSCIENCE
卷 125, 期 3, 页码 344-349

出版社

AMER PSYCHOLOGICAL ASSOC
DOI: 10.1037/a0023572

关键词

prefrontal; dopamine; response conflict; schizophrenia; cognitive control

资金

  1. National Alliance for Research into Schizophrenia and Depression
  2. BBSRC [BB/EO11969]
  3. NHMRC [568872]
  4. BBSRC [BB/E011969/1] Funding Source: UKRI
  5. Biotechnology and Biological Sciences Research Council [BB/E011969/1] Funding Source: researchfish

向作者/读者索取更多资源

It has been proposed that the cognitive dysfunction observed in patients with schizophrenia reflects a failure in cognitive control, in particular an inability to use task-relevant information to guide behavior. Using a prefrontal-dependent task designed to reflect aspects of cue and response conflict seen in human cognitive paradigms, we examined the influence of prefrontal dopamine receptor manipulation on the contextual control of response conflict. Rats were trained on two biconditional discrimination tasks, one auditory and one visual, in two discriminably different contexts. At test, audiovisual compounds of these training stimuli were presented, in extinction, in each of the training contexts. These compounds were formed in such a way that the individual elements previously dictated different responses during training, termed incongruent trials. Studies have shown that rats use contextual information to disambiguate the conflicting information provided by incongruent compounds, responding in manner that is appropriate to the stimulus element that was trained in the test context. Direct infusion of the D1 receptor agonist SKF-38393 into the prelimbic cortex was found to modulate incongruent trial performance in a manner that was dependent upon baseline performance: animals in the low baseline group demonstrated improved incongruent performance following infusion of SKF-38393 into the prelimbic cortex. In contrast, high performers showed a reduction in accuracy during incongruent compounds. This paradigm provides a reliable framework for assessing the efficacy of preclinical agents in treating the cognitive impairments seen in frontal-related disorders such as schizophrenia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据